Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis

Adnan Erol1

  • 1Silivri City Hospital, Department of Internal Medicine, Ali Cetinkaya Cad, 34930 Silivri, Istanbul, Turkey. eroladnan@hotmail.com

Medical Hypotheses
|May 21, 2005
PubMed

Insights

Mitochondrial dysfunction triggers retrograde regulation, altering cellular metabolism and promoting cancer development. This mitochondrial signaling pathway influences gene activation, cell survival, and organismal energy balance, potentially involving MYC transcription factors.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Mitochondrial dysfunction is a key factor in cancer development.
  • Mitochondria communicate with the nucleus through retrograde signaling in response to functional alterations.
  • This signaling impacts cellular metabolism, proliferation, and survival.

Purpose of the Study:

  • To elucidate the role of mitochondrial retrograde regulation in carcinogenesis.
  • To understand how mitochondrial dysfunction influences cellular pathways and organismal metabolism.
  • To identify key molecular players, such as transcription factors, involved in this process.

Main Methods:

  • Analysis of mitochondrial electron transport chain function.
  • Investigation of cytosolic protein transport to the nucleus.
  • Examination of gene activation in response to mitochondrial stress.
  • Metabolic pathway analysis, including glyoxylate cycle and futile cycles.

Main Results:

  • Mitochondrial dysfunction leads to nuclear gene activation, affecting metabolic, regulatory, and stress pathways.
  • Retrograde signaling promotes a shift towards a unicellular-like metabolism, utilizing fat for glucose via the glyoxylate cycle.
  • This process contributes to cachexia and enhances tumor progression, metastasis, and apoptosis resistance.
  • MYC is identified as a potential transcription factor involved in the retrograde response.

Conclusions:

  • Mitochondrial retrograde regulation is a critical mechanism in cancer, driving metabolic adaptation and promoting tumor survival.
  • Dysfunctional mitochondria reprogram cellular metabolism, leading to energy depletion in the host organism.
  • Targeting retrograde signaling pathways, potentially involving MYC, may offer new therapeutic strategies for cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...